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Abstract
Introduction. Unlike malignant liver tumours, the indications for hepatic resection for benign disease are not well defined.
This is particularly true for focal nodular hyperplasia (FNH). Here we summarize a single-centre experience of the diagnosis
and management of FNH. Materials and methods. Using a prospectively collected database, a retrospective analysis of
consecutive patients who were managed at our centre for FNH between January 1997 and December 2006 was performed.
Results. The cohort was divided into two groups of patients: those who were managed surgically (n15) and those managed
conservatively (n37). There was no correlation between tumour size and number of lesions with oral contraceptive use
(p0.07 and 0.90, respectively) and pregnancy (p0.45 and 0.60, respectively). However, tumour size (p0.006) and
number of lesions (p0.02) were associated with the occurrence of pain in these patients. Pain was the commonest
symptom of patients (13/15) who were managed surgically. All patients underwent radiological imaging before diagnosis.
The sensitivities of ultrasound, CT scanning and MRI scanning in characterizing these lesions were 30%, 70% and 87%,
respectively. There were no postoperative deaths and three postoperative complications that were successfully managed
non-operatively. With a median follow-up of 24 months in the surgically treated group, one patient has developed recurrent
symptoms of pain. Conclusion. In this series, there was no mortality directly due to the surgical procedure and a modest
morbidity, justifying surgical resections in selected patients.
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Introduction
Focal nodular hyperplasia (FNH) is one of the most
common benign neoplasms of the liver and accounts
for 8% of all primary hepatic tumours. It is more
commonly found in women, although it can present
with smaller lesions and atypical features in men [1].
Frequently, the lesion is picked up incidentally but can
also present with vague abdominal symptoms due to
the mass effect causing pain and bloatedness. Contrast-
enhanced MRI scanning has been shown to be the most
sensitive modality for characterizing this lesion [2].
However, imaging techniques such as Doppler ultra-
sound and CT scanning are also frequently used. The
distinction between benign and malignant lesions still
remains difficult, but crucial, as the treatment of the
two conditions remains distinctly different.
FNH is not a premalignant lesion [3,4]. Therefore,
unlike premalignant and malignant tumours, the
indications for hepatic resection for benign disease
are not as well defined. This is particularly true for
FNH, where the indications for surgery include
progressive disease, increasing pain and lesions where
malignancy cannot be excluded.
Although there continues to be marked improve-
ment in outcomes of hepatic resections, the proce-
dure is still associated with a mortality and morbidity
rate ofB5% and 30%, respectively, emphasizing the
importance of clear indications for surgery in benign
diseases such as FNH. Here we summarize a single-
centre experience of the diagnosis and management
of FNH including those treated surgically and
conservatively.
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Materials and methods
Between January 1997 and June 2006, patients with
focal nodular hyperplasia at our centre were evalu-
ated. The patients’ medical, radiological and surgical
records were reviewed retrospectively. Data collected
included patient age, sex, symptoms, risk factors,
comorbidity, liver function tests, tumour markers,
radiological findings, preoperative diagnosis, indica-
tions for operations, surgical procedures, postopera-
tive diagnosis, length of hospital stay, postoperative
complications and progress on follow-up. All patients
and radiographic studies were presented and dis-
cussed at a weekly multi-disciplinary hepatobiliary
meeting between surgeons, hepatologists, radiologists
and pathologist.
The patients were retrospectively divided into
surgically and non-surgically managed groups and
compared. Patients considered for surgical resection
for symptomatology, underwent further investigations
to exclude other diagnoses such as cholelithiasis and
gastritis. Patients with suspicious lesions underwent
additional preoperative investigations to evaluate the
extent of disease. If the lesion remained radiologically
suspicious, surgical resection was carried out. Con-
servative management was indicated in non-sympto-
matic lesions with a clear diagnosis of FNH. These
patients were followed up with radiological imaging at
6 months.
Statistical analysis was performed using SPSS
12.0.1 for Windows (SPSS, Chicago, IL, USA).
Categorical and continuous variables were analysed
using x2 and independent sample t test, respectively.
Results
In the 10-year study period, a total of 52 patients were
diagnosed with FNH at our unit. The diagnosis of
lesions was based on radiological and pathological
findings for both the surgically and non-surgically
managed groups (Table I).
The two groups were comparable for patient
demographics (Table II). The median age of the
surgically and conservatively managed groups was
40 and 36 years, respectively, with 47 women sufferers
(90%) in the whole cohort. In total, 64% (30 patients)
of these women were on the oral contraceptive pill
(OCP) at the time of diagnosis and 62% (29 patients)
had a previous pregnancy. There was no significant
difference in ASA grade, liver function and tumour
marker levels between the groups.
All patients underwent radiological imaging before
diagnosis. The most frequent radiological imaging
modality used at our centre for investigating these
lesions was MRI scanning (Table III). The sensitiv-
ities of ultrasound, CT scanning and MRI scanning in
characterizing these lesions were 30%, 70% and 87%,
respectively. Aside from these modalities, four HIDA
scans were performed to rule out gallbladder dyski-
nesia as a cause of pain.
The indication for surgical resection was a suspi-
cious lesion on radiological investigation or persistent
pain in a clear diagnosis of FNH. This is evident on
comparing the two groups, where a significantly
greater number of patients had pain and suspicious
lesions in the surgical group (Table II).
The surgical procedures performed on these pa-
tients included three trisegmentectomies, three lobe-
comies, one segmentectomy and eight non-anatomical
resections. On histopathological analysis of the re-
sected specimen occasionally other neoplasms were
found incidentally with the FNH lesions. These
included five adenomas and one hepatocellular carci-
noma (HCC).
The median hospital stay was 9 days in the surgical
group. There were no postoperative deaths. One
patient developed chest infections requiring parent-
eral antibiotic therapy, one subhepatic abcess that
required percutaneous drainage and one wound
infection.
With a median follow-up of 24 months (range 672
months), there has been one death in the patients
treated for FNH. This was in a patient who was found
to have a HCC in the resected specimen.
Of the surgically treated group two patients have
developed recurrence of FNH, at 29 and 48 months
Table I. FNH diagnostic criteria for surgically and non-surgically managed groups.
Diagnostic criteria Number (clinical features)
Surgical group (n15)
Definitive radiological diagnosis 6 (all resected for pain)
Inconclusive radiological diagnosis; definitive preoperative
pathological diagnosis
2 (all resected for pain)
Suspicious lesion on radiological investigation 4*
Suspicious lesion on radiological and preoperative
pathological investigation
3*
Non-surgical group (n37)
Definitive radiological diagnosis 30 (minor symptoms, n10; asymptomatic, n20)
Inconclusive radiological diagnosis; definitive
pathological diagnosis
7
*FNH diagnosed on postoperative histopathology.
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post resection, respectively, with the former develop-
ing minor symptoms of pain. In the conservatively
managed group, with a median follow-up of 23
months (range 384 months), five patients group
continue to complain of atypical pain and are cur-
rently under investigation for this prior to considera-
tion of resection.
Discussion
Along with haemangiomas, FNH is currently one of
the most common benign lesions of the liver. It is
predominantly found in women, with most series
reporting the incidence in men to beB15% [5].
Luciani et al reported that when occurring in men,
these lesions are frequently atypical, occurring at a
later age and of a smaller size [1]. In this study of 52
patients, we report a 47:5 female to male ratio. Of
note, comparing men to women, the mean age at
diagnosis was 43 compared to 37 (p0.18) and mean
tumour size was 4.6 cm compared to 3.8 cm,
respectively (p0.47).
Unlike hepatic adenomas, the role of the OCP and
pregnancy in the development and complications of
FNH remains controversial [2,6,7]. Here 64% and
62% of the 47 women in the study were on the OCP
and had had pregnancies before the diagnosis of
FNH. There was no correlation between tumour
size and number of lesions with OCP use (p0.07
and 0.90, respectively) and pregnancy (p0.45 and
0.60, respectively). These findings were similar to
previously published findings [8]. The OCP was not
stopped in conservatively managed patients with a
clear diagnosis of FNH and there was no change in
character on follow-up radiology.
Pain was the commonest symptom of patients with
this lesion and persistence of this pain was used as an
indication for surgery in these patients. For the whole
cohort of patients, tumour size (p0.006) and
number of lesions (p0.02) were associated with
the occurrence of pain. Because the persistence of
pain was an indication for surgery, there were a
significantly greater number of patients in the surgi-
cally managed group who suffered with pain and a
significantly larger number of patients in the con-
servatively managed group that had lesions discovered
incidentally.
Radiological imaging is invaluable in diagnosing the
conditions. Many recent publications have shown that
MRI scanning remains the gold standard for this
purpose [2,9]. In this study the majority (88%) of
patients had MRI scanning to characterize these
lesions. However, the sensitivity of a clear diagnosis
of FNH remained suboptimal at 87%. Lesions that
were thought to be suspicious on radiological imaging
were considered for resection. Resections were per-
formed on seven FNH lesions that were thought to
look suspicious on radiological investigations.
In the surgically managed group, three trisegmen-
tectomies, three lobectomies, one segmentectomy and
eight non-anatomical resections were performed. For-
mal anatomical resections were carried out in radi-
ologically suspicious lesions. On histopathological
Table II. Characteristics of surgically and conservatively managed patients.
Characteristic Surgical group (n15) Conservative group (n37) Statistical difference between groups
Demographics
Age 40 (2066) 36 (2456)
Sex (female:male) 14:1 33:4 NS
OCP use 11/14 19/33
Pregnancy 8/14 21/33
Symptoms
Pain 13/15 (moderate/severe) 13/37 (mild) 0.001
Incidental 1 19 0.001
Clinical investigations
Suspicious lesion 7 0 B0.0001
ASA
Grade 1 14/15 34/37 NS
Grade 2 1/15 3/37
Tumour size (cm) 6.1 3.2 0.01
No. of lesions 2 2 NS
Biochemical investigations
Normal LFTs 13 30 NS
Normal tumour markers 11/11 27/28 NS
LFT, liver function test.
Table III. Use and sensitivities of US, CT and MRI scanning for
FNH.
Imaging modality
Number
performed
Sensitivity in diagnosing
FNH [number (%)]
Ultrasound 27/52 8 (30%)
CT scanning 34/52 24 (70%)
MRI scanning 46/52 40 (87%)
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analysis of the resected specimens, five of these lesions
were found to have a simultaneous adenoma and one
of these lesions was found to have a HCC. The
simultaneous occurrence of FNH and hepatic adeno-
mas is thought to be favoured by angiogenic abnorm-
alities, tumour-induced growth factors, thrombosis
and local arteriovenous shunting or co-incidental [7].
Associations between FNH and HCC have rarely been
described, with two published reports of FNH asso-
ciated with the fibrolamellar variant of HCC [1012].
With a median postoperative stay of 9 days, there
was minimal morbidity and no mortality in this
cohort. Three patients developed postoperative com-
plications from a wound infection, chest infection and
a subhepatic abscess that were successfully managed
non-operatively. There was generally a low morbidity
associated with the open surgical resections. In a bid
to further improve on the morbidity of liver resections
for benign disease, some centres have shown encoura-
ging results in laparoscopic resections, with results
that are at least as good as open surgery [13,14].
On long-term follow-up (mean of 22 months),
there was one mortality in a patient who was found
to have a concomitant HCC. This patient went on to
develop portal vein thrombosis from tumour progres-
sion and, having shown no response to chemotherapy,
succumbed to his illness 24 months post resection.
Two patients in the surgically managed groups have
developed recurrent disease and one of these was
symptomatic 29 months after surgery. This compares
with five patients with atypical pain in the non-
operative group, who are currently under investigation
to rule out other disease as a cause, prior to
consideration for resection.
In conclusion, FNH is a benign lesion of the liver that
can cause pain that is associated with the increase in size
of the lesion. Surgical resection is usually performed for
persistent pain or for lesions that are suspicious on
radiological and pathological investigations. We pro-
pose a management algorithm for the diagnosis and
management of these patients (Figure 1). In this series,
using these criteria, there has been no mortality directly
due to the surgical procedure and a modest morbidity,
justifying surgical resections in selected patients.
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